Air Pollution study: HEPA filtration
Official title Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
ClinicalTrials.gov ID: NCT05867381
What this study is testing
- What it's testing
- The study wants to find out whether using indoor air filtration reduces the progression of atherothrombosis (clot‑forming artery disease).
- Who it's for
- Adults with a history of ischemic heart disease.
- What's involved
- Participants will use an air‑filter device in their home for a set period, then switch to a control device, while researchers measure changes in their arteries and monitor air quality.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 84
You may be able to join if
- Age between 65 and 84 years old;
- Weight ≥ 110 pounds;
- Nonsmokers for at least 1 year;
- Have ischemic heart disease history, clinically stable for 6 months, without any deterioration in symptoms or episodes of angina based on past...
- Both English and Spanish speaking participants will be included in the recruitment;
You likely can't join if
- Have history of degenerative disease of the nervous system such as dementia and Alzheimer's;
- Currently have active cancer treatments;
- The residential house has already had HEPA filters;
- Participants will move out from the current residential address in the next 2 years;
- Participants will spend more than 1 month living outside the primary home;
- Have any health conditions that prohibit collecting health and covariate data and biospecimens;
See the full eligibility criteria
- Age between 65 and 84 years old;
- Weight ≥ 110 pounds;
- Nonsmokers for at least 1 year;
- Have ischemic heart disease history, clinically stable for 6 months, without any deterioration in symptoms or episodes of angina based on past electronic medical records;
- Both English and Spanish speaking participants will be included in the recruitment;
- Live in the Los Angeles County.
- Have history of degenerative disease of the nervous system such as dementia and Alzheimer's;
- Currently have active cancer treatments;
- The residential house has already had HEPA filters;
- Participants will move out from the current residential address in the next 2 years;
- Participants will spend more than 1 month living outside the primary home;
- Have any health conditions that prohibit collecting health and covariate data and biospecimens;
- Participants' residential houses are not feasible for setting up air purifiers and air pollutants monitors.
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 84 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.